Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/476040 stock hub

KOSDAQ/476040 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/476040is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

130.1B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/476040

In the news

Latest news · KOSDAQ/476040

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.4

P25 n/aP50 n/aP75 n/a

ROIC-36.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/476040 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

KRW

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 118.8B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 130.1B
Price	KRW 19,760
Price currency	KRW
Sic	2834
Symbol	kosdaq/476040
Website	https://organoidrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.81%
EV Earnings	-7.73x
EV/FCF	-7.46x
EV/Sales	49.35x
FCF yield	-12.23%
P/B ratio	5.24x
P/S ratio	54.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	97.98%
Gross Profit	KRW 2.4B
Gross Profit Growth	23.42%
Gross Profit Growth Q	-10.4%
Net Income	KRW -15.4B
Pretax Margin	-654%
ROA	-32.1
ROCE	-54.6
ROE	-78.43
ROIC	-36.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	23.21x
Revenue Growth Q	-10.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.08
Assets	KRW 37.2B
Cash	KRW 18.6B
Current Assets	KRW 20B
Current Liabilities	KRW 7.5B
Debt	KRW 7.1B
Debt Equity	KRW 0.28
Debt FCF	KRW -0.44
Equity	KRW 24.8B
Interest Coverage	-44.59
Liabilities	KRW 12.3B
Long Term Assets	KRW 17.2B
Long Term Liabilities	KRW 4.8B
Net Cash	KRW 11.6B
Net Cash By Market Cap	KRW 8.88
Net Cash Growth	42.61%
Net Debt Equity	KRW -0.47
Tangible Book Value	KRW 24.1B
Tangible Book Value Per Share	KRW 3,665

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.66
Net Working Capital	KRW -2.6B
Quick ratio	2.55
Working Capital	KRW 12.5B
Working Capital Turnover	KRW 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-46.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	32,239.3
50-day SMA	24,679.2
50-day SMA vs 200-day SMA	50under200
All Time High	52,000
All Time High Change	-62%
All Time High Date	2025-05-21
All Time Low	19,600
All Time Low Change	0.82%
All Time Low Date	2026-05-08
ATR	1,359.7
Beta1y	1.01
Beta2y	1.01
Ch YTD	-48.41
High	21,000
High52	52,000
High52 Date	2025-05-21
High52ch	-62%
Low	19,600
Low52	19,600
Low52 Date	2026-05-08
Low52ch	0.82%
Ma50ch	-19.93%
Price vs 200-day SMA	-38.71%
RSI	32.29
RSI Monthly	0
RSI Weekly	30.77
Sharpe ratio	-0.23x
Sortino ratio	-0.28
Total Return	-46.1%
Tr YTD	-48.41
Tr1m	-4.54%
Tr1w	-10.18%
Tr3m	-32.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -16.2B
Operating margin	-673.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,687,460%
Net Borrowing	-473,783,560
Shares Insiders	28.61%
Shares Institutions	19.22%
Shares Out	6,585,760
Shares Qo Q	0.3%
Shares Yo Y	46.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -16.7B
Average Volume	87,162.35x
Bv Per Share	3,752.5
CAPEX	KRW -1.9B
Ch1m	-4.54
Ch1w	-10.18
Ch3m	-32.79
Ch6m	-38.35
Change	-2.66%
Change From Open	-2.66
Close	20,300
Days Gap	0
Depreciation Amortization	1,444,767,580
Dollar Volume	1,679,738,320
Earnings Date	2026-04-10
EBIT	KRW -16.2B
EBITDA	KRW -14.8B
EPS	KRW -2,517
F Score	4
FCF	KRW -15.9B
FCF EV Yield	-13.4x
FCF Per Share	KRW -2,416
Financing CF	25,406,878,750
Fiscal Year End	December
Founded	2,018
Investing CF	-8,182,242,250
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Ma150	31,743.4
Ma150ch	-37.75%
Ma20	22,655.5
Ma20ch	-12.78%
Net CF	3,292,119,270
Open	20,300
Position In Range	11.43
Ppne	8,464,069,410
Price Date	2026-05-08
Ptbv Ratio	5.4
Relative Volume	0.98x
Revenue	2,406,581,880x
SBC By Revenue	34.51x
Share Based Comp	830,570,440
Tr6m	-38.35%
Volume	85,007
Z Score	6.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/476040 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns KOSDAQ/476040?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.2%

Share of float held by funds and institutions

Insider ownership

+28.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+46.1%

Negative means the company is buying back shares.

Technical

KOSDAQ/476040 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.3

Neutral momentum band

Price vs 200-day MA

-38.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/476040

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/476040 stock rating?

kosdaq/476040 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/476040 analysis?

The full report lives at /stocks/kosdaq/476040/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/476040?

The latest report frames kosdaq/476040 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/476040 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.